Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem | Journal of Epidemiology & Community Health

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Commentary

Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	883	907	125
Mar 2022	984	980	178
Apr 2022	567	564	67
May 2022	156	152	51
Jun 2022	129	123	29
Jul 2022	70	66	12
Aug 2022	60	55	13
Sep 2022	50	47	26
Oct 2022	86	85	26
Nov 2022	37	36	15
Dec 2022	60	56	6
Jan 2023	44	44	11
Feb 2023	56	50	34
Mar 2023	42	40	54
Apr 2023	60	56	17
May 2023	26	27	7
Jun 2023	29	27	5
Jul 2023	34	33	11
Aug 2023	29	24	6
Sep 2023	35	34	14
Oct 2023	40	37	9
Nov 2023	32	31	10
Dec 2023	49	49	28
Jan 2024	28	28	9
Feb 2024	18	18	10
Mar 2024	47	42	27
Total	3651	3611	800